LIGHT-INDUCED FLUORESCENCE SPECTROSCOPY AND OPTICAL COHERENCE TOMOGRAPHY OF BASAL CELL CARCINOMA

EKATERINA BORISOVA; ELFRIDA CARSTEA; LUMINITA CRISTESCU; ELMIRA PAVLOVA; NIKOLAY HADJIOLOV; PETRANKA TROYANOVA; LATCHEZAR AVRAMOV

[1] S. Danon, Z. Valerianova, T. Ivanova, Cancer Incidence in Bulgaria 2004, volume XV, Bulgarian National Cancer Registry, Publisher “AVIS-24” Ltd. (2007).

[2] E. Borisova, E. Nikolova, P. Troyanova, L. Avramov, “Autofluorescence and diffuse reflectance spectroscopy of pigment disorders in human skin,” JOAM 10, 717–722 (2008).

[3] S. Svanberg, “Environmental and medical applications of photonic interactions,” Physica Scripta T110, 39–50 (2004).

[4] L. Bachmann, D. Zezell, A. da Costa Ribeiro, L. Gomes, A. Ito, “Fluorescence spectroscopy of biological tissues — A review,” Appl. Spectr. Rev. 41, 575–590 (2006).

[5] Y. Sinichkin, S. Utz, A. Mavliutov, H. Pilipenko, “In vivo fluorescence spectroscopy of the human skin: Experiments and models,” J. Biomed. Opt. 3, 201–211 (1998).

[6] R. Na, I. Stender, L. Ma, H.Wulf, “Autofluorescence spectrum of skin: Component bands and body site variations,” Skin Res. Tech. 6, 112–117 (2000).

[7] N. Kollias, G. Zonios, G. Stamatas, “Fluorescence spectroscopy of skin,” Vibrational Spectroscopy 28, 17–23 (2002).

[8] V. Mantareva, D. Petrova, L. Avramov, I. Angelov, E. Borisova, M. Peeva, D. Woehrle, “Long wavelength absorbing cationic Zn(II)-phthalocyanines as fluorescent contrast agents for B16 pigmented melanoma,” J. Porphyr. Phthalocyan. 9, 47–53 (2005).

[9] S. Andersson-Engels, J. Johansson, U. Stenram, K. Svanberg, S. Svanberg, “Malignant tumor and atherosclerotic plaque diagnosis using laser-induced fluorescence,” IEEE J. Quantum Elect. 26, 2207– 2217 (1990).

[10] T. Vo-Dinh, B. Cullum, “Fluorescence spectroscopy for biomedical diagnostics,” Chap. 28 in Biomedical Photonics Handbook, T. Vo-Dinh, Ed., CRC Press (2003).

[11] V. Mantareva, V. Kussovski, I. Angelov, E. Borisova, L. Avramov, D. Woehrle, “Photodynamic activity of water-soluble phthalocyanine zinc(II) complexes against pathogenic microorganisms,” Bioorg. Med. Chem. 15, 4829–4835 (2007).

[12] J. Moan, L. W. Ma, V. Iani, “On the pharmacokinetics on topically applied 5-aminolevulinic acid and two of its esters,” Int. J. Cancer 92, 139–143 (2001).

[13] H. Ahn, S. Kim, Y. Kye, “Fluorescence digital photography of acne using a light-emitting diode illuminator,” Skin Res. Tech. 12, 289–291 (2006).

[14] E. Borisova, L. Avramov, “Laser system for optical biopsy and in vivo study of the human skin,” Proc. SPIE 4397, 405–409 (2001).

[15] H. Li, B. Standish, A. Mariampillai, N. Munce, Y. Mao, S. Chiu, N. Marcon, B. Wilson, A. Vitkin, V. Yang, “Feasibility of interstitial doppler optical coherence tomography for in vivo detection of microvascular changes during photodynamic therapy,” Las. Surg. Med. 38, 754–761 (2006).

[16] S. Boppart, W. Luo, D. Marks, K. Singletary, “Optical coherence tomography: Feasibility for basic research and image-guided surgery of breast cancer,” Breast Cancer Res. Treat. 84, 85–97 (2004).

[17] W. Jung, B. Kao, K. Kelly, L. Liaw, J. Nelson, Z. Chen, “Optical coherence tomography for in vitro monitoring of wound healing after laser irradiation,” IEEE J. Select. Topics Quant. Elect. 9, 222–226 (2003).

[18] R. Steiner, K. Kunzi-Rapp, K. Scharffetter- Kochanek, “Optical coherence tomography: Clinical applications in dermatology,” Med. Las. Appl. 18, 249–259 (2003).

[19] T. J rgensen, A. Tycho, M. Mogensen, P. Bjerring, G. Jemec, “Machine-learning classification of nonmelanoma skin cancers from image features obtained by optical coherence tomography,” Skin Res. Tech. 14, 364–369 (2008).

[20] M. Mogensen, T. Joergensen, B. Nurnbe, H. Morsy, J. Thomsen, L. Thrane, G. Jemec, “Assessment of optical coherence tomography imaging in the diagnosis of non-melanoma skin cancer and benign lesions versus normal skin: Observer-blinded evaluation by dermatologists and pathologists,” Dermatologic Surgery, Published Online: 8 Apr 2009, doi: 10.1111/j.1524-4725.2009.01164.x.

[21] V. Korde, G. Bonnema, W. Xu, C. Krishnamurthy, J. Ranger-Moore,K. Saboda, L. Slayton, S. Salasche, J. Warneke, D. Alberts, J. Barton, “Using optical coherence tomography to evaluate skin sun damage and precancer,” Las. Surg. Med. 39, 687– 695 (2007).

[22] H. Moseley, Non-Ionizing Radiation: Microwaves, Ultraviolet and Laser Radiation, J. W. Arrowsmith Ltd., Bristol, UK (1988).

[23] N. Gladkova, N. Shakhova, B. Shakhov, “Optic coherent tomography: A new high-resolution technology of visualization of tissue structures. Communication II. Optical images of benign and malignant entities,” Vestn. Rentgenol. Radiol. Mar–Apr (2), 44–54 (2004).

[24] H. Hong, J. Sun, W. Cai, “Anatomical and molecular imaging of skin cancer,” Clin. Cosmetic Invest. Dermatology 1, 1–17 (2008).

[25] H. Buchwald, A. Muller, J. Kampmeier, “Optical coherence tomography versus ultrasound biomicroscopy of conjunctival and eyelid lesions,” Klin. Monatsbl. Augenheilkd. 220, 822–829 (2003).

[26] J. K. Barton, A. R. Tumlinson, U. Utzinger, “Combined endoscopic optical coherence tomography and laser induced fluorescence,” in Optical Coherence Tomography — Technology and Applications, W. Drexler, J. Fujimoto, Eds., Springer (2008).

[27] L.Wang, H. Wu, Biomedical Optics: Principles and Imaging, Wiley-Interscience (2007).

[28] R. Kuranov, V. Sapozhnikova, H. Shakhova, V. Gelikonov, E. Zagainova, S. Petrova. “Combined application of optical methods to increase the information content of optical coherent tomography in diagnostics of neoplastic processes,” Quantum Electronics 32, 993–998 (2002).